Mia's Feed
Medical News & Research

Disparities in Achieving Diabetes Care Goals Among Patient Groups in Primary Care Program

Disparities in Achieving Diabetes Care Goals Among Patient Groups in Primary Care Program

Share this article

A recent study reveals differences in how racial and ethnic groups meet diabetes management goals within a primary care program, emphasizing the need for culturally tailored approaches to reduce healthcare disparities.

2 min read

A recent study evaluated the effectiveness of the Enhanced Primary Care Diabetes (EPCD) model, a nurse-led approach that integrates multidisciplinary support to improve diabetes management in primary care settings. Published in The Annals of Family Medicine, the research focused on whether different racial and ethnic groups benefited equally from this program.

The study analyzed health records from 1,749 adults aged 18 to 75 years across 13 family and internal medicine practices affiliated with Mayo Clinic Rochester, covering data from January 1 to December 31, 2020. Patient progress was tracked until August 1, 2022, to assess how quickly they achieved five key diabetes care goals, collectively known as D5. These include maintaining blood pressure below 140/90 mmHg, using statin therapy to lower cholesterol, achieving an HbA1c level under 8%, remaining tobacco-free, and regularly taking aspirin when indicated.

The analysis revealed that 60.7% of patients met all five targets during the study period. Notably, Black patients were significantly less likely than white patients to reach these goals, with a hazard ratio of 0.68. While Asian and Hispanic patients showed similar outcomes to white patients overall, differences emerged in the frequency of nurse interactions: Asian patients had fewer nurse touchpoints (median 0.8 per year), whereas Black patients engaged more frequently (median 2.2 per year). Hispanic patients' engagement was comparable to white patients.

Factors such as younger age, insulin use, fewer baseline care goal components, and a lower medication count at the time of program initiation were associated with slower achievement of the D5 targets. Interestingly, despite increased nursing support, Black patients faced greater challenges in reaching their diabetes management goals, emphasizing the need for tailored approaches that consider socioeconomic and cultural contexts.

This study underscores the importance of addressing disparities in chronic disease management and highlights the necessity for culturally sensitive interventions in primary care models to ensure equitable health outcomes for all racial and ethnic groups.

For more details, see the original study: Diabetes care delivery and outcomes by race and ethnicity: evaluation of an enhanced primary care practice model in the US Upper Midwest.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Peer Influence Significantly Contributes to Youth Vaping Crisis, New Research Shows

Research from the University of Queensland highlights how peer influence drives the increasing trend of vaping and cannabis use among adolescents, emphasizing the need for targeted regulation and awareness campaigns.

Breakthrough in Cuff-Free Blood Pressure Monitoring Using Optical Technology

Researchers have developed a groundbreaking optical technology using speckle contrast spectroscopy (SCOS) for cuffless blood pressure monitoring, offering more comfortable and continuous cardiovascular tracking.

Impact of Rural Hospital Closures on Healthcare Costs and Access

Rural hospital closures reduce access to care and lead to higher prices at surviving hospitals, increasing healthcare costs and impacting rural communities. A recent study highlights these critical issues and calls for policy attention.

Allopurinol Recognized as the First Orphan Drug for Marfan Syndrome Treatment

The EMA has designated allopurinol as the first orphan drug for treating Marfan syndrome, opening new avenues for managing this rare connective tissue disorder with vascular complications. Ongoing research explores its potential to prevent life-threatening aortic aneurysms.